Cancer survival in European adolescents and young adults.

摘要: Survival of patients aged 15-24 years, diagnosed with cancer during the period 1990-1994, is described within Europe. Data on 15 101 patients, extracted from files 56 adult registries included in EUROCARE-3 database, representing 20 European countries, were analysed and compared. Five-year survival for 'all cancers combined' was 75% males (ranging 59% Estonia to 89% Iceland), 78% females Norway). The Northern countries (except Denmark) Austria had highest figures, while Eastern lower than average. Denmark, UK, pool central intermediate figures. Haemopoietic tumours most common malignancies: 5-year high Hodgkin's disease (89%), non-Hodgkin's lymphoma (68%) acute lymphoblastic leukaemia (ALL) (47%) myeloblastic (AML) (39%). gonadal germ cell cancers, second malignancy young adults, 90%. other under consideration as follows: skin melanoma, 66% all Central Nervous System (CNS) tumours, 57% bone 58% osteosarcoma, 42% Ewing's sarcoma, soft-tissue sarcomas, 99% thyroid carcinoma, 82% uterine cervical 83% ovarian carcinoma. For more 'adult-specific tumours', good colon (77%) lung (60%) less favourable, compared breast (68%). Adolescents (15-19 years) significantly worse adults (20-24 malignancies combined. lymphoma, CNS melanoma showed marked regional variability. Since many occurring are curable, these results should encourage, without delay, efforts identify obstacles improving outcome reducing geographical inequalities this group patients.